Fresenius Medical Care introduces multiFiltratePRO, a new therapy system for acute dialysis

Everybody who has to fulfill demanding tasks with the help of technical devices during their daily clinical routine needs a sense of safety and reliability. The more extensive the tasks are the more important is the easy and intuitive handling of the complex technology. Fresenius Medical Care’s multiFiltratePRO is specifically tailored to meet these needs.

Dominik Wehner, chief executive officer for Europe, Middle East and Africa commented: “User-friendly operations, reliability as well as the usage for various extracorporeal therapies are the key strengths of this new therapy system multiFiltratePRO. This powerful technology increases efficiency and ergonomics and is equally easy to operate.”

A multitude of features supports physicians and caregivers who are increasingly experiencing raising workloads and high working pressure: a large touch screen monitor comprehensively displays all needed information; intuitive handling; fully integrated fluid heaters reliably provide the right temperature of the fluid; a “Care-Mode” prevents unnecessary alarms and a functional chassis allows easy mobility also in the narrow space at the bedside.

The multiFiltratePRO platform is based on modern technology and builds on substantial experience with our successfully established Ci-Ca® regional anticoagulation which results in less bleeding for the patients.

Dr. Olaf Schermeier, chief executive officer for Global Research and Development stated: “Over the time we expect to expand this new therapy platform. The reliable and simple user interface helps reducing the demand on personnel while providing the highest treatment quality. And spending less time with handling complex technology offers the opportunity to pay more attention to the patient itself.”